Massimo Riccaboni
TitleCited byYear
The productivity crisis in pharmaceutical R&D
F Pammolli, L Magazzini, M Riccaboni
Nature reviews Drug discovery 10 (6), 428, 2011
A comparison of US and European university-industry relations in the life sciences
J Owen-Smith, M Riccaboni, F Pammolli, WW Powell
Management science 48 (1), 24-43, 2002
Technological change and network dynamics: lessons from the pharmaceutical industry
L Orsenigo, F Pammolli, M Riccaboni
Research policy 30 (3), 485-508, 2001
Innovation and corporate growth in the evolution of the drug industry
G Bottazzi, G Dosi, M Lippi, F Pammolli, M Riccaboni
International Journal of Industrial Organization 19 (7), 1161-1187, 2001
Does co-location matter for formal knowledge collaboration in the Swedish biotechnology–pharmaceutical sector?
M McKelvey, H Alm, M Riccaboni
Research policy 32 (3), 483-501, 2003
The growth of business firms: Theoretical framework and empirical evidence
D Fu, F Pammolli, SV Buldyrev, M Riccaboni, K Matia, K Yamasaki, ...
Proceedings of the National Academy of Sciences 102 (52), 18801-18806, 2005
Innovation and competitiveness in European biotechnology
F Pammolli, A Allansdottir, A Bonaccorsi, A Gambardella, M Mariani, ...
Office for Official Publications of the European Communities, 2002
Reputation and impact in academic careers
AM Petersen, S Fortunato, RK Pan, K Kaski, O Penner, A Rungi, ...
Proceedings of the National Academy of Sciences 111 (43), 15316-15321, 2014
Dynamic competition in pharmaceuticals
L Magazzini, F Pammolli, M Riccaboni
The European Journal of Health Economics, formerly: HEPAC 5 (2), 175-182, 2004
The evolution of knowledge and the dynamics of an industry network
L Orsenigo, F Pammolli, M Riccaboni, A Bonaccorsi, G Turchetti
Journal of Management & Governance 1 (2), 147-175, 1997
The sustainability of European health care systems: beyond income and aging
F Pammolli, M Riccaboni, L Magazzini
The European Journal of Health Economics 13 (5), 623-634, 2012
On firm growth in networks
M Riccaboni, F Pammolli
Research Policy 31 (8-9), 1405-1416, 2002
Medical devices competitiveness and impact on public health expenditure
F Pammolli, M Riccaboni, C Oglialoro, L Magazzini, G Baio, N Salerno
Persistence and uncertainty in the academic career
AM Petersen, M Riccaboni, HE Stanley, F Pammolli
Proceedings of the National Academy of Sciences, 2012
On the size distribution of business firms
J Growiec, F Pammolli, M Riccaboni, HE Stanley
Economics Letters 98 (2), 207-212, 2008
The productivity crisis in pharmaceutical RD citation_author= F Pammolli
L Magazzini, M Riccaboni
Nat Rev Drug Discov 10 (6), 428-438, 2011
On size and growth of business firms
G De Fabritiis, F Pammolli, M Riccaboni
Physica A: Statistical Mechanics and its Applications 324 (1-2), 38-44, 2003
Betweenness centrality of fractal and nonfractal scale-free model networks and tests on real networks
M Kitsak, S Havlin, G Paul, M Riccaboni, F Pammolli, HE Stanley
Physical Review E 75 (5), 056115, 2007
World input-output network
F Cerina, Z Zhu, A Chessa, M Riccaboni
PloS one 10 (7), e0134025, 2015
Evolution of controllability in interbank networks
D Delpini, S Battiston, M Riccaboni, G Gabbi, F Pammolli, G Caldarelli
Scientific reports 3, 1626, 2013
The system can't perform the operation now. Try again later.
Articles 1–20